In their research article published in the September 9, 2005 issue of Cell, Hammes et al. (2005) investigated the role of megalin (an endocytic receptor in a variety of tissues) and SHBG (sex hormone binding globulin) on the cellular uptake of sex steroid hormones in mice. In plasma, androgens and estrogens can circulate bound tightly to SHBG, bound loosely to albumin, unbound, or free. Although oversimplified, the currently favored view-called the free hormone hypothesis-postulates that it is the free and albumin bound forms of sex steroid hormones that are available for diffusion out of capillaries and into cells, where they initiate an appropriate response. Hammes et al. (2005) report that megalin enables, and is crucial for, the internalization of sex steroids bound to SHBG, suggesting an alternative pathway for the uptake of sex steroid hormones. However, there are several important points that raise questions about the conclusions drawn from this study. Hammes et al. (2005) used both an in vitro model, the BN16 cell line that expresses megalin, and an in vivo model, the megalin knockout mouse (Nykjaer et al., 1999) , to examine the interactions among megalin, SHBG, and certain sex steroids. Mice lacking megalin are severely deficient in vitamin D, and this deficiency has been reported to be associated with impaired gonadal development and function (Kinuta et al., 2000) . Thus, it is possible that it is a deficiency in vitamin D and not a lack of megalin that causes the reproductive abnormalities observed by Hammes et al. in their megalin knockout mice. Furthermore, the adult mouse liver does not synthesize SHBG and there is no SHBG in adult mouse plasma (Janne et al., 1999) . Thus, findings related to the importance of SHBG in the uptake of steroids and in steroid hormone action in this mouse model are unlikely to yield biologically relevant results. In addition, whereas the BN16 cell line expresses megalin, it does not express receptors for androgens and estrogens, calling into question the physiological relevance of studies on the uptake of steroid hormones in these cells.
There are several other concerns regarding this study. The authors analyzed the specificity of the megalin-SHBG interaction both before and after denaturation of megalin (see Hammes et al., 2005, Figure 1A ). Although SHBG does not bind to denatured megalin, the binding of megalin to denatured SHBG was not investigated. It is feasible that megalin, which is known to bind to a large variety of protein and nonprotein ligands (Christensen and Birn, 2002) , may be able to bind biologically inactive 125 I-SHBG resulting in a misinterpretation of these experiments.
The authors ascertained the uptake of 3 H-testosterone by BN16 cells from media containing SHBG ( Figure 1C ), but only after a 5 hr incubation. They did not chemically characterize the molecules that had incorporated the 3 H-label-it could have been incorporated into any number of metabolites of testosterone. In the absence of kinetic data, it is not clear whether other events confounded the interpretation of the results, such as rapid uptake of testosterone with its subsequent release into the medium. Testosterone is known to rapidly enter cells in vitro and to be metabolized extensively; the metabolites exist in cells and are released into the medium (Smith et al., 1994) . When Hammes et al. (2005) incubated BN16 cells with a 5-fold excess of SHBG (500 nM) relative to 3 H-testosterone, only 11% of the 3 H-label was associated with the cells (Figure 1C ). Furthermore, the 3 H-compounds were not identified. If the suggestion by Hammes et al.-that sex steroid hormones bound to SHBG are taken up by cells with the help of megalin-were correct, then one would expect more than 11% uptake of the bound steroid. At zero time, essentially all of the 3 H-testosterone is bound; thus the steroid uptake should have been roughly equal to the 40% uptake for 125 I-SHBG seen in a separate experiment ( Figure 1B) . The demonstration that the megalin antagonist RAP (receptorassociated protein) almost totally blocks 3 H-testosterone uptake does not clarify this issue. One could argue that the high concentration of SHBG (500 nM) ( Figure 1C ) decreases its percentage uptake from the 40% demonstrated at lower SHBG concentrations (1 nM) ( Figure 1B) . This could have been tested by examining the percentage uptake of 500 nM 125 I-SHBG. Nevertheless, it is unlikely that the discrepancy between the uptake of 125 I-SHBG and the uptake of 3 H-testosterone can be attributed to a decreased percentage uptake of 125 I-SHBG because there is little change in 3 H-testosterone uptake as the SHBG concentration is increased from 10 to 500 nM, or as the ratio of SHBG to testosterone is increased from 1:10 to 5:1. When the concentration of SHBG is 10 nM and that of testosterone is 100 nM, then 99.9% of 3 H-testosterone is free and about 10% of the added (100 nM) 3 H-testosterone is taken up by cells. When the percent of free 3 H-testosterone is <0.5% (achieved by incubation of 500 nM SHBG with 100 nM 3 H-testosterone), the same percentage (10%) of the added 3 H-testosterone is taken up by cells. These observations are difficult to reconcile with a model that posits uptake of bound testosterone. Certainly, SHBG does not appear to be necessary for cellular uptake of testosterone under these circumstances. Hammes et al. (2005) also investigated uptake of the testosterone metabolite 3 H-dihydrotestosterone (DHT), a potent androgen in its own right, and of 3 Hestradiol in a keratinocyte cell line that does not express megalin ( Figure 1F) . They show about 1% uptake by the cells but again do not supply kinetic and chemical data. Others have shown that when the HaCaT keratinocyte cell line is incubated with 3 H-testosterone in culture medium lacking SHBG, of the 93% of the 3 H-label observed in the medium, only 7% of the 3 H represents unmetabolized testosterone (Altenburger and Kissel, 1999 Figure 2A ), others are not (for example, see Figures 2B and 2C) . At a concentration of 1 nM DHT plus 1 nM SHBG, 50% of the steroid exists in the free form. One nanomole of DHT-SHBG and 1 nM DHT are equally effective at entering cells and activating an androgen-responsive reporter gene ( Figure 2B ); SHBG alone is about 25% as effective at activating the reporter gene as DHT alone. The most reasonable interpretation is that free DHT is the active species and that SHBG itself has a modest effect (through mechanisms not explained by these experiments). RAP almost completely inhibits activation of the reporter gene by 1 nM DHT-SHBG, despite the fact that half of the DHT is unbound at this concentration. In contrast, 1 nM DHT alone is not blocked by RAP and yields the same increase in reporter gene activation as 1 nM DHT-SHBG. It is clear that SHBG is not necessary for DHT to enter the cell and to activate the reporter gene.
Thus, the conclusion by Hammes et al. that there is a megalin-mediated endocytic pathway for the uptake of androgens and estrogens bound to their SHBG proteins does not seem to be sufficiently supported by the evidence presented.
Note All percentages for free steroids are calculated from the law of mass action for steroid protein interactions using the equations set out by Sodergard et al. (1982) . The dissociation constants (Kd) used in the calculations are 1 nM for the binding of testosterone to SHBG, and 0.5 nM for the binding of DHT to SHBG.
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